A non-randomized, Open study with aripiprazole and ziprasidone for the treatment of aggressive behavior in youth in a community clinic

Community Mental Health Journal

Volumn 45, Issue 1, 2009, Pages 73-77

  Bastiaens, Leo ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Aggression; Aripiprazole; Children and adolescents; Ziprasidone

Indexed keywords

ARIPIPRAZOLE; ZIPRASIDONE;

ADOLESCENT; AGGRESSION; AGITATION; ARTICLE; BEHAVIOR DISORDER; BLURRED VISION; CHILD; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; DIZZINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HEALTH CENTER; HUMAN; INTERVIEW; JUVENILE; LOADING DRUG DOSE; MALE; MENTAL PATIENT; NAUSEA; OPEN STUDY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PSYCHOLOGIC ASSESSMENT; PSYCHOPHARMACOTHERAPY; RATING SCALE; SCHOOL CHILD; SEDATION; SIDE EFFECT; TREATMENT OUTCOME; WEIGHT GAIN;

ADOLESCENT; AGGRESSION; ANTIPSYCHOTIC AGENTS; CHILD; COMMUNITY MENTAL HEALTH CENTERS; FEMALE; HUMANS; MALE; PIPERAZINES; QUINOLONES; THIAZOLES; TREATMENT OUTCOME;

EID: 58849123230     PISSN: 00103853     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10597-008-9154-7     Document Type: Article

References (26)

1. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity (2004). Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care, 27, 596-601.
2. D Barzman MP Delbello RA Kowatch B Gernert DE Fleck S Pathak K Rappoport SV Delgado P Campbell SM Strakowski 2004 The effectiveness and tolerability of Aripiprazole for pediatric bipolar disorders: A retrospective chart review Journal of Child and Adolescent Psychopharmacology 14 593 600
3. Bastiaens, L., & Bastiaens, D. (2005). Pediatric experience with Aripiprazole. New Research Abstracts, 158th Annual Meeting, A.P.A., p. 157.
4. Bastiaens, L., & Dello Stritto, C. (2004). Validity and reliability of the health and life functioning scale. Scientific Proceedings, 51st Annual Meeting, A.A.C.A.P., p. 108.
5. Biederman, J., Mick, E., Harpold, T., Hammerness, P., Doyle, R., Aleardi, M., et al. (2006). Open-label study of Aripiprazole in youth with bipolar disorder. New Research Abstracts, 159th Annual Meeting, A.P.A., p. 262.
6. J Biederman MA McDonnell J Wozniak T Spencer M Aleardi R Falzone E Mick 2005 Aripiprazole in the treatment of pediatric bipolar disorder: A systematic chart review CNS Spectrums 10 141 148
7. JK Buitelaar RJ van der Gaag P Cohen-Kettenis CT Melman 2001 A randomized, controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities The Journal of Clinical Psychiatry 62 239 248
8. Coccaro, E., & McNamee, B. (1998). Biology of aggression: Relevance to crime. In: Skodol, A. E. (Ed.), Psychopathology and violent crime (pp. 99-128). Washington, DC: Am Psych Press.
9. Connor, D. F. (2002). Aggression and antisocial behavior in children and adolescents: Research and treatment. NY: Guilford Publications, Inc.
10. Dejong, S., Giuliano, A. J., & Frazier, J. A. (2004). Antipsychotic medications. In H. Steiner (Ed.), Handbook of mental health interventions in children and adolescents: An integrated developmental approach. San Francisco, CA: Wiley/Jossey-Bass.
11. Deutschman, D. A., & Deutschman, D. H. (2005). Efficacy and safety of Ziprasidone in youths with Axis I diagnoses. New Research Abstracts, 158th Annual Meeting, A.P.A., p. 161.
12. RL Findling NK McNamara LA Branicky MD Schluchter E Lemon JL Blumer 2000 A double-blind pilot study of risperidone in the treatment of conduct disorder Journal of the American Academy of Child and Adolescent Psychiatry 39 509 516
13. Gadow, K. D., & Sprafkin, J. (1997). Adolescent symptom inventory (vol. 4). Stony Brook, NY: Checkmate Plus Ltd.
14. BL Gracious RL Findling 2001 Antipsychotic medications for children and adolescents Pediatric Annals 30 138 145
15. Guy, W. (1976). Early clinical drug evaluation unit (ECDEU) assessment manual for psychopharmacology (pp. 217-222). Bethesda, MD: NIMH Publication.
16. WR Marchand SC Clark L Wirth C Simon 2005 Validity of the parent young mania rating scale in community mental health setting Psychiatry 2 31 35
17. A Martin L Scahill GM Anderson M Aman LE Arnold J McCracken CJ McDougle E Tierney S Chuang B Vitiello 2004 Weight and leptin changes among risperidone-treated youths with autism: 6-months prospective data American Journal of Psychiatry 161 1125 1127
18. McConville, B. J., & Sorter, M. T. (2004). Treatment challenges and safety considerations for antipsychotic use in children and adolescents with psychoses. Journal of Clinical Psychiatry, 65(Suppl 6), 20-29.
19. McCracken, J. T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M. G., et al., for the Research Units on Pediatric Psychopharmacology Autism Network (2002). Risperidone in children with autism and serious behavioral problems. The New England Journal of Medicine, 347, 314-321.
20. NC Patel ML Crismon K Hoagwood PS Jensen 2005 Unanswered questions regarding atypical antipsychotic use in aggressive children and adolescents Journal of Child and Adolescent Psychopharmacology 15 270 284
21. NC Patel RJ Sanchez MT Johnsrud ML Crismon 2002 Trends in antipsychotic use in a Texas medicaid population of children and adolescents: 1996-2000 Journal of Child and Adolescent Psychopharmacology 12 221 229
22. S Ruths H Steiner 2004 Psychopharmacologic treatment of aggression in children and adolescents Pediatric Annals 33 318 327
23. FR Sallee R Kurlan CG Goetz 2000 Ziprasidone treatment of children and adolescents with Tourette's syndrome: A pilot study Journal of the American Academy of Child and Adolescent Psychiatry 39 292 299
24. DV Sheehan Y Lecrubier K Harnett Sheehan J Janav E Weiller A Keskines J Schinka E Knapp MF Sheehan GL Dunbar 1997 The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability European Psychiatry 12 232 241
25. R Snyder A Turgay M Aman C Binder S Fisman A Carroll for the Risperidone Conduct Study Group 2002 Effects of risperidone on conduct and disruptive behavioral disorders in children with subaverage IQs Journal of the American Academy of Child and Adolescent Psychiatry 41 1026 1036
26. SC Yudofsy JM Silver W Jackson 1986 The overt aggression scale for the objective rating of verbal and physical aggression American Journal of Psychiatry 143 35 39